首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   104924篇
  免费   9714篇
  国内免费   7011篇
耳鼻咽喉   1244篇
儿科学   1045篇
妇产科学   747篇
基础医学   10424篇
口腔科学   1627篇
临床医学   11765篇
内科学   13201篇
皮肤病学   1222篇
神经病学   4444篇
特种医学   4895篇
外国民族医学   19篇
外科学   13552篇
综合类   21500篇
现状与发展   27篇
一般理论   5篇
预防医学   8177篇
眼科学   2115篇
药学   11145篇
  91篇
中国医学   6810篇
肿瘤学   7594篇
  2024年   366篇
  2023年   1499篇
  2022年   3698篇
  2021年   4867篇
  2020年   3866篇
  2019年   3077篇
  2018年   3189篇
  2017年   3263篇
  2016年   3118篇
  2015年   4828篇
  2014年   6005篇
  2013年   6507篇
  2012年   9182篇
  2011年   9607篇
  2010年   7412篇
  2009年   6244篇
  2008年   6905篇
  2007年   6701篇
  2006年   6129篇
  2005年   5301篇
  2004年   3894篇
  2003年   3662篇
  2002年   3194篇
  2001年   2324篇
  2000年   1680篇
  1999年   1209篇
  1998年   649篇
  1997年   657篇
  1996年   502篇
  1995年   404篇
  1994年   332篇
  1993年   185篇
  1992年   190篇
  1991年   193篇
  1990年   147篇
  1989年   120篇
  1988年   106篇
  1987年   83篇
  1986年   67篇
  1985年   46篇
  1984年   30篇
  1983年   19篇
  1982年   27篇
  1981年   18篇
  1979年   19篇
  1978年   22篇
  1977年   12篇
  1975年   12篇
  1974年   12篇
  1973年   12篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
83.
PurposeDissection after plain balloon angioplasty is required to achieve adequate luminal area; however, it is associated with a high risk of vascular events. This study aimed to examine the relationship between non-flow limiting coronary dissections and subsequent lumen loss and long-term clinical outcomes following successful drug-coated balloon (DCB) treatment of de novo coronary lesions.Materials and MethodsA total of 227 patients with good distal flow (Thrombolysis in Myocardial Infarction flow grade 3) following DCB treatment were retrospectively enrolled and stratified according to the presence or absence of a non-flow limiting dissection. The primary endpoint was late lumen loss (LLL) at 6-month angiography, and the secondary endpoint was target vessel failure (TVF, a composite of cardiac death, target vessel myocardial infarction, target vessel revascularization, and target vessel thrombosis).ResultsThe cohort consisted of 95 patients with and 132 patients without a dissection. There were no between-group differences in LLL (90.8%) returning for angiography at 6 months (0.05±0.19 mm in non-dissection and 0.05±0.30 mm in dissection group, p=0.886) or in TVF (6.8% in non-dissection and 8.4% in dissection group, p=0.799) at a median follow-up of 3.4 years. In a multivariate analysis, the presence of dissection and its severity were not associated with LLL or TVF. Almost dissections (93.9%) were completely healed, and there was no newly developed dissection at 6-month angiography.ConclusionThe presence of a dissection following successful DCB treatment of a de novo coronary lesion may not be associated with an increased risk of LLL or TVF (Impact of Drug-coated Balloon Treatment in de Novo Coronary Lesion; NCT04619277).  相似文献   
84.
Cells of patients with ataxia telangiectasia (AT), an inheriteddisease characterized by a high propensity to cancer, are hypersensitiveto ionizing radiation. We investigated whether the hyper-radiosensitivityof AT cells correlated with a defect in their constitutive and/orconditional ability to rescue a damaged exogenous virus. Forthat purpose, parvovirus H-1, a single-stranded DNA virus whoseintranuclear replication mostly relies on host cell functions,was used as a probe. The survival of u.v.-or -irradiated H-1was measured in X-, u.v.- or mock-irradiated human cells ofnormal (NB-E) or AT (AT5BIVA) origin. -irradiated H-1 survivedto similar extents in untreated normal and AT cell lines. BothX- and u.v.-irradiatlon induced normal cells to achieve an enhancedreactivation (ER) of -- or u.v.-damaged H-1. In contrast, neitherdose-effect curves nor time course revealed significant levelsof ER expression after X- or u.v.-irradiation in AT5BIVA cells.Our results suggest that the impairment of ER of damaged parvovirusesmay constitute a marker of the AT cell phenotype and be relatedto the radiosensitivity of AT cells.  相似文献   
85.
86.
Radiation therapy is widely used in the treatment of tumor diseases, but it can also cause serious damage to the body, so it is necessary to find effective nutritional supplements. The main purpose of this study is to evaluate the protective effect of whey hydrolysate peptides (WHPs) against 60Coγ radiation damage in mice and explore the mechanism. BALB/c mice were given WHPs by oral gavage administration for 14 days. Then, some mice underwent a 30-day survival test after 8 Gy radiation, and other mice received 3.5 Gy radiation to analyze the changes in body weight, hematology and bone marrow DNA after three and 14 days. In addition, through further analysis of the level of oxidative stress and intestinal barrier function, the possible mechanism of the radioprotective effect of WHPs was explored. The study found WHPs can prolong survival time, restore body weight, and increase the number of peripheral blood white blood cells and bone marrow DNA content in irradiated mice. In addition, WHPs can significantly improve the antioxidant capacity, inhibit pro-inflammatory cytokines and protect the intestinal barrier. These results indicate that WHPs have a certain radioprotective effect in mice, and the main mechanism is related to reducing oxidative damage.  相似文献   
87.
88.
目的 研讨非开胸食管内翻剥脱的手术方法、优缺点及适应症。方法 :分析我院 1 992年至 2 0 0 0年 6月非开胸食管内翻剥脱胃重建食管术的 1 8例病历 ,其中下咽癌 5例、甲状腺鳞癌 1例、喉癌侵犯下咽者 4例、食管颈段癌 8例。结果 :本组病人食管床出血量均在 1 0 0ml以下 ,无吻合口漏等严重并发症 ,无手术死亡。结论 :本手术安全具有简便创伤小的优点 ,适用于颈段食管癌、下咽癌及甲状腺癌和喉癌侵及下咽者、部分早期食管癌和贲门癌。  相似文献   
89.
目的:认识多发伤中骨折的主要特点,探讨内固定在救治中的意义。方法:回顾1994-08~1999-08间手术救治多发伤66例,对其161处骨折中的98处进行了“仿AO技术”有关方法内固定。结果:骨折均满意愈合;涉及骨折关节51个,功能恢复满意率为96.08%。结论:在多发伤中,骨折、合并伤与并发症远较“一般骨折”复杂、严重;有效固定骨折是一种重要的救命措施;内固定手术应争取在伤后24h进行,但如受条件制约,伤后1-3wk内手术也可获得满意效果;仿AO技术中的某些方法,如拉力螺钉、张力带钢丝及自动加压钢板等,用于内固定可使骨折获得卓有成效的稳定性。  相似文献   
90.
目的:评价^32P灌注球囊预防再狭窄的有效性、可行性和安全性。方法:对猪冠状动脉左前降支行过度球囊扩张术后,治疗组以^32P作血管内照射,对照组作假照射。术后35d收获目标血管、检测血管形态、细胞增殖百分比等。结果:治疗组血管腔面积较对照组明显增大(P<0.01),新生内膜面积、血管狭窄程度和各层PCNA阳性细胞明显减小(P均<0.01)。结论:^31P灌注球囊照射预防冠状动脉再狭窄有效、安全而且可行。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号